首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1471955

連續性腎臟替代療法市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、方式和最終用戶

Continuous Renal Replacement Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Modality, and End User

出版日期: 2024年03月18日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

根據我們最新的《2030 年連續性腎臟替代療法市場預測 - 全球分析 - 產品、方式、最終用戶和地理》研究顯示，2022 年市場估值為 14.2 億美元，預計將達到 27.5 億美元到 2030 年；預計2022年至2030年複合年成長率為8.7%。

連續性腎臟替代治療 (CRRT) 已成為入住 ICU 接受 AKI 治療的兒童的建議透析選擇。由於多種兒科疾病的存在，兒科人群中腎臟替代的適應症發生了變化。 CRRT 的應用範圍已擴大，其在治療非腎臟適應症（主要是危重新生兒）的有效性已得到證實。例如，Medtronic 的 Carpediem 系統為低體重患者提供專用的體外 CRRT；根據該公司的說法，該設備可以有效地滿足最脆弱患者的需求。此外，百特的 PRISMASOL 和 PHOXILLUM 解決方案被指定為 CRRT 中的替代解決方案，以取代超濾去除的血漿量，並糾正兒科和成人患者的電解質和酸鹼失衡。因此，對兒科 CRRT 設備的需求增加有利於腎臟替代治療市場的持續成長。

按產品分類，持續腎臟替代療法市場洞察

根據產品，連續性腎臟替代療法市場分為透析液和替代液、一次性用品、血管套件和管道、CRRT 系統和血液過濾器。 CRRT 系統細分市場在 2022 年佔據最大市場佔有率。血濾器由中空纖維膜組成，可控制排出的液體和溶質的體積。透過消除溶質（廢物、電解質和其他分子），CRRT 濾血器膜模仿腎臟的一些活動。此外，它們還可以透過其功能來幫助恢復體液狀態和酸鹼平衡。

按最終用戶，持續腎臟替代治療市場洞察

依最終用戶分類，連續腎臟替代治療市場分為醫院、門診護理中心、家庭護理等。 2022年，醫院細分市場將主導持續性腎臟替代治療市場。家庭監控領域預計在 2022 年至 2030 年期間複合年成長率最高。根據美國醫院協會的數據，到 2023 年，美國有 5,157 家社區醫院、206 家聯邦政府醫院和 107 家其他醫院。此外，老年人口的不斷成長和 AKI 住院人數的顯著增加是推動醫院 CRRT 系統需求的關鍵因素。

美國國立衛生研究院、公司的投資者報告和世界衛生組織是在準備連續性腎臟替代療法市場報告時提到的一些主要二手來源。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 東南亞其他地區
中東和非洲
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 13 章：連續腎臟替代治療市場 - 主要公司概況

Baxter International Inc
Asahi Kasei
Fresenius Medical Care
Medica S.p.A.
Medtronic Plc
B. Braun
Nikkiso Co Ltd
Toray Medical Co Ltd
Infomed SA
Quanta Dialysis Technologies Inc

第 14 章：附錄

簡介目錄

Product Code: TIPHE100001251

According to our latest study on " Continuous Renal Replacement Therapy Market Forecast to 2030 - Global Analysis -Product, Modality, End User, and Geography," the market was valued at US$ 1.42 billion in 2022 and is expected to reach US$ 2.75 billion by 2030; it is estimated to register a CAGR of 8.7% from 2022 to 2030.

Continuous renal replacement therapy (CRRT) has become the recommended dialysis option for children admitted to ICUs for AKI treatments. The indications for renal replacement in the pediatric population have changed due to a wide range of pediatric diseases. The range of CRRT applications has expanded with its proven effectiveness in treating nonrenal indications, primarily, in critically ill newborns. For instance, the Carpediem system by Medtronic offers a dedicated extracorporeal CRRT for low-weight patients; as per the company's claims, the device responds effectively to the needs of the most fragile patients. Moreover, PRISMASOL and PHOXILLUM solutions by Baxter are indicated as a replacement solution in CRRT to replace plasma volume removed by ultrafiltration as well as to correct electrolyte and acid-base imbalances in pediatric and adult patients. Thus, the increased demand for pediatric CRRT devices benefits the continuous renal replacement therapy market growth.

By Product, Continuous Renal Replacement Therapy Market-Based Insights

Based on product, the continuous renal replacement therapy market is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022. The hemofilters segment is likely to register the highest CAGR in the market during 2022-2030. The hemofilters are composed of a hollow-fiber membrane that controls the volume of fluids and solutes evacuated. By eliminating solutes (waste products, electrolytes, and other molecules), CRRT hemofilter membranes imitate some of the activities of the kidney. Moreover, they may help restore fluid status and acid-base balance through their function.

By End User, Continuous Renal Replacement Therapy Market-Based Insights

The continuous renal replacement therapy market, by end-user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospital segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022-2030. In 2023, the US had 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals, according to the American Hospital Association. Further, the growing elderly population and the notable rise in hospital admissions for AKI are the key factors that propel the demand for CRRT systems in hospitals.

National Institutes of Health, company's investor reports, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the continuous renal replacement therapy market.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Continuous Renal Replacement Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Continuous Renal Replacement Therapy Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Continuous Renal Replacement Therapy Market - Global Market Analysis

6.1 Continuous Renal Replacement Therapy - Global Market Overview
6.2 Continuous Renal Replacement Therapy - Global Market and Forecast to 2030

7. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Product, 2020-2030

7.1 Overview
7.2 Dialysates and Replacement Fluids
7.3 Disposables
7.4 Bloodline Sets and Tubes
7.5 Hemofilters
7.6 CRRT Systems

8. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Modality, 2020-2030

8.1 Overview
8.2 Continuous venovenous hemofiltration (CVVH)
8.3 Continuous venovenous hemodiafiltration (CVVHDF)
8.4 Continuous venovenous hemodialysis (CVVHD)
8.5 Slow continuous ultrafiltration (SCUF)

9. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospital
9.3 Ambulatory care
9.4 Homecare
9.5 Others

10. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Continuous Renal Replacement Therapy Market Overview
- 10.1.2 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts to 2030
- 10.1.3 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Modality
- 10.1.5 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Continuous Renal Replacement Therapy Market
    - 10.1.6.1.1 United States Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.1.2 United States Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.1.3 United States Continuous Renal Replacement Therapy Market, by End User
  - 10.1.6.2 Canada Continuous Renal Replacement Therapy Market
    - 10.1.6.2.1 Canada Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.2.2 Canada Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.2.3 Canada Continuous Renal Replacement Therapy Market, by End User
  - 10.1.6.3 Mexico Continuous Renal Replacement Therapy Market
    - 10.1.6.3.1 Mexico Continuous Renal Replacement Therapy Market, by Product
    - 10.1.6.3.2 Mexico Continuous Renal Replacement Therapy Market, by Modality
    - 10.1.6.3.3 Mexico Continuous Renal Replacement Therapy Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of SouthEast Asia
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 U.A.E
- 10.4.3 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Continuous Renal Replacement Therapy Market - Key Company Profiles

13.1 Baxter International Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies